Wealthspire Advisors (New York)’s Galectin Therapeutics GALT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.01M | Buy |
|
|||||
|
2025
Q1 | $486K | Hold |
|
|||||
|
2024
Q4 | $514K | Hold |
|
|||||
|
2024
Q3 | $1.1M | Hold |
|
|||||
|
2024
Q2 | $900K | Hold |
|
|||||
|
2024
Q1 | $952K | Buy |
|
|||||
|
2023
Q4 | $305K | Hold |
|
|||||
|
2023
Q3 | $353K | Hold |
|
|||||
|
2023
Q2 | $265K | Hold |
|
|||||
|
2023
Q1 | $386K | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $28K | Hold |
|
|||||
|
2022
Q2 | $23K | Hold |
|
|||||
|
2022
Q1 | $28K | Buy |
|
|||||
|
2021
Q4 | $29K | Hold |
|
|||||
|
2021
Q3 | $54K | Hold |
|
|||||
|
2021
Q2 | $44K | Hold |
|
|||||
|
2021
Q1 | $30K | Hold |
|
|||||
|
2020
Q4 | $31K | Hold |
|
|||||
|
2020
Q3 | $37K | Hold |
|
|||||
|
2020
Q2 | $42K | Hold |
|
|||||
|
2020
Q1 | $27K | Hold |
|
|||||
|
2019
Q4 | $40K | Hold |
|
|||||
|
2019
Q3 | $51K | Buy |
|